Showing 1,461 - 1,480 results of 1,890 for search '"type II diabetes"', query time: 0.15s Refine Results
  1. 1461

    Quantitative Proteomic Analysis of Hepatic Tissue of T2DM Rhesus Macaque by Tingfu Du, Shuaiyao Lu, Qinfang Jiang, Yun Li, Kaili Ma

    Published 2017-01-01
    “…Type 2 diabetes mellitus (T2DM) is a metabolic disorder that severely affects human health, but the pathogenesis of the disease remains unknown. …”
    Get full text
    Article
  2. 1462

    Proinflammatory Cytokine Expression in Apical Periodontitis from Diabetic Patients by Estéfano Borgo Sarmento, Rosana Helena Teixeira de Lima Ribeiro Andrade, Cinthya Cristina Gomes, Fábio Ramôa Pires, Maria Isabel Bastos Valente, Adalgiza Mafra Moreno, Marco Orsini, Dennis Carvalho Ferreira, Lucio Souza Gonçalves, Luciana Armada

    Published 2023-01-01
    “…Therefore, this study evaluated the immunoexpression of IL-1β, TNF-α, and IL-17 in apical periodontitis from type 2 diabetic patients through immunohistochemistry. …”
    Get full text
    Article
  3. 1463
  4. 1464

    Paradoxical Glucose-Sensitizing yet Proinflammatory Effects of Acute ASP Administration in Mice by Alexandre Fisette, Pegah Poursharifi, Katerina Oikonomopoulou, Mercedes N. Munkonda, Marc Lapointe, Katherine Cianflone

    Published 2013-01-01
    “…Acylation stimulating protein (ASP) is an adipokine derived from the immune complement system, which stimulates fat storage and is typically increased in obesity, type 2 diabetes, and cardiovascular disease. Using a diet-induced obesity (DIO) mouse model, the acute effects of ASP on energy metabolism and inflammatory processes in vivo were evaluated. …”
    Get full text
    Article
  5. 1465

    Natural compounds in the management of polycystic ovary syndrome: a comprehensive review of hormonal regulation and therapeutic potential by Jingyi Yuan, Zhenmin Li, Yongjiang Yu, Xiuge Wang, Yunyun Zhao

    Published 2025-02-01
    “…This disorder affects approximately 6–20% of individuals, primarily emerging during early adolescence, and considerably increases the risk of conditions such as impaired glucose tolerance, type 2 diabetes, endometrial cancer, cardiovascular diseases, dyslipidemia, and postpartum complications. …”
    Get full text
    Article
  6. 1466

    The Role of Helicobacter pylori Seropositivity in Insulin Sensitivity, Beta Cell Function, and Abnormal Glucose Tolerance by Lou Rose Malamug, Rudruidee Karnchanasorn, Raynald Samoa, Ken C. Chiu

    Published 2014-01-01
    “…Infection, for example, Helicobacter pylori (H. pylori), has been thought to play a role in the pathogenesis of type 2 diabetes mellitus (T2DM). Our aim was to determine the role of H. pylori infection in glucose metabolism in an American cohort. …”
    Get full text
    Article
  7. 1467

    Increased Peripheral Proinflammatory T Helper Subsets Contribute to Cardiovascular Complications in Diabetic Patients by Ru-xing Zhao, Wen-juan Li, Yi-ran Lu, Jun Qin, Chuan-long Wu, Meng Tian, Tian-yi He, Shou-nan Yi, Dong-qi Tang, Lei Sun, Li Chen

    Published 2014-01-01
    “…Coronary atherosclerotic heart disease (CHD) is one of the major concerns in type 2 diabetes (T2D). The systemic chronic inflammation has been postulated to bridge the increased risk of cardiovascular disease and T2D. …”
    Get full text
    Article
  8. 1468

    The Effect of Time-Restricted Eating on Insulin Levels and Insulin Sensitivity in Patients with Polycystic Ovarian Syndrome: A Systematic Review by R. Floyd, R. Gryson, D. Mockler, J. Gibney, S. N. Duggan, L. A. Behan

    Published 2022-01-01
    “…Polycystic ovarian syndrome (PCOS) is the most common reproductive endocrinopathy in women of reproductive age with many associated metabolic symptoms, in particular hyperinsulinemia, insulin resistance, and a high lifetime risk of type 2 diabetes mellitus. The effects of time-restricted eating on metabolic profiles have been investigated in many endocrinopathies, but there is minimal data for PCOS. …”
    Get full text
    Article
  9. 1469

    The Relationship between Estimated Glomerular Filtration Rate and Diabetic Retinopathy by Jingyang Wu, Jin Geng, Limin Liu, Weiping Teng, Lei Liu, Lei Chen

    Published 2015-01-01
    “…This is a hospital-based study and the aim of it was to examine the relationship between the GFR and DR in patients with type 2 diabetes mellitus (T2DM). We used CKD-EPI equation to estimate GFR and SPSS 19.0 and EmpowerStats software to assess their relationship. …”
    Get full text
    Article
  10. 1470

    Prediabetes risk classification algorithm via carotid bodies and K-means clustering technique by Rafael F. Pinheiro, Maria P. Guarino, Marlene Lages, Rui Fonseca-Pinto

    Published 2025-01-01
    “…In the search for methods to support early diagnosis, this article introduces a novel prediabetes risk classification algorithm (PRCA) for type-2 diabetes mellitus (T2DM), utilizing the chemosensitivity of carotid bodies (CB) and K-means clustering technique from the field of machine learning. …”
    Get full text
    Article
  11. 1471
  12. 1472

    The protective role of GLP-1 in neuro-ophthalmology by Sohum Sheth, Aashay Patel, Marco Foreman, Mohammed Mumtaz, Akshay Reddy, Ramy Sharaf, Siddharth Sheth, Brandon Lucke-Wold

    Published 2023-08-01
    “…Glucagon-like peptide 1 receptor agonists (GLP-1RAs), traditionally used in the treatment of type 2 diabetes, are becoming increasingly appreciated for their diverse applications. …”
    Get full text
    Article
  13. 1473
  14. 1474

    SGLT-2 Inhibitors—a Culprit of Diabetic Ketoacidosis Postbariatric Surgery by Qasim Zafar Iqbal, Danil Mishiyev, Muhammad Raphay Niazi, Zeeshan Zia, Saud Bin Abdul Sattar, Abdullah Jahanghir, Shahed Quyyumi

    Published 2020-01-01
    “…We present a case series of three cases of euglycemic DKA postbariatric surgery in patients with an underlying history of type 2 diabetes mellitus, who were being treated with SGLT2 inhibitors prior to the surgery. …”
    Get full text
    Article
  15. 1475

    Choosing between GLP-1 Receptor Agonists and DPP-4 Inhibitors: A Pharmacological Perspective by Dominique Xavier Brown, Marc Evans

    Published 2012-01-01
    “…In recent years the incretin therapies have provided a new treatment option for patients with type 2 diabetes mellitus (T2DM). The incretin therapies focus on the increasing levels of the two incretin hormones, glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). …”
    Get full text
    Article
  16. 1476

    Healthy Chilean Adolescents with HOMA-IR ≥ 2.6 Have Increased Cardiometabolic Risk: Association with Genetic, Biological, and Environmental Factors by R. Burrows, P. Correa-Burrows, M. Reyes, E. Blanco, C. Albala, S. Gahagan

    Published 2015-01-01
    “…Family history of type 2 diabetes (FHDM) was reported. We determined the optimal cutoff of HOMA-IR to diagnose MetS (IDF criteria) using ROC analysis. …”
    Get full text
    Article
  17. 1477

    Low-grade sarcoma of the cervix: an unusual diagnosis by Maurice José González Basulto, Gustavo de Jesús Crespo Campo, Dayan Cervantes Peláez

    Published 2024-01-01
    “…Patient information: 72-year-old woman, with a history of high blood pressure, type 2 diabetes mellitus and surgery for fibroid, along with necrobiosis, who had to undergo total abdominal hysterectomy with double adnexectomy. …”
    Get full text
    Article
  18. 1478

    High Fasting Plasma Glucose during Early Pregnancy: A Review about Early Gestational Diabetes Mellitus by E. Cosson, L. Carbillon, P. Valensi

    Published 2017-01-01
    “…Although eGDM is characterized by insulin resistance and associated with classical risk factors for type 2 diabetes and incident diabetes after delivery, it is not necessarily associated with preexisting prediabetes. …”
    Get full text
    Article
  19. 1479

    Time-Series Analysis of Continuously Monitored Blood Glucose: The Impacts of Geographic and Daily Lifestyle Factors by Sean T. Doherty, Stephen P. Greaves

    Published 2015-01-01
    “…Type 2 diabetes is known to be associated with environmental, behavioral, and lifestyle factors. …”
    Get full text
    Article
  20. 1480

    The CNDP1 (CTG)5 Polymorphism Is Associated with Biopsy-Proven Diabetic Nephropathy, Time on Hemodialysis, and Diabetes Duration by Thomas Albrecht, Shiqi Zhang, Jana D. Braun, Li Xia, Angelica Rodriquez, Jiedong Qiu, Verena Peters, Claus P. Schmitt, Jacob van den Born, Stephan J. L. Bakker, Alexander Lammert, Hannes Köppel, Peter Schnuelle, Bernhard K. Krämer, Benito A. Yard, Sibylle J. Hauske

    Published 2017-01-01
    “…Considering that the homozygous CNDP1 (CTG)5 genotype affords protection against diabetic nephropathy (DN) in female patients with type 2 diabetes, this study assessed if this association remains gender-specific when applying clinical inclusion criteria (CIC-DN) or biopsy proof (BP-DN). …”
    Get full text
    Article